Alexion Pharmaceuticals
Alexion Pharmaceuticals, Inc (NASDAQ: ALXN) | World Leader in Treatments for Patients with Devastating and Rare Diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD53.2b (Public information from Dec 2020)
Share price
€15.55 ALXN
Boston Massachusetts (HQ)
Authorizing premium user...